Litigation Details for Allergan, Inc. v. Ferrum Ferro Capital, LLC (C.D. Cal. 2015)
✉ Email this page to a colleague
Allergan, Inc. v. Ferrum Ferro Capital, LLC (C.D. Cal. 2015)
| Docket | ⤷ Try a Trial | Date Filed | 2015-06-19 |
| Court | District Court, C.D. California | Date Terminated | 2015-12-28 |
| Cause | 28:1441 Notice of Removal | Assigned To | John Arnold Kronstadt |
| Jury Demand | Plaintiff | Referred To | Magistrate Judge Paul L. Abram |
| Patents | 7,030,149; 7,320,976; 7,323,463; 7,642,258; 8,133,890; 8,354,409; 8,748,425 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Allergan, Inc. v. Ferrum Ferro Capital, LLC
The small molecule drug covered by the patents cited in this case is ⤷ Try a Trial .
Details for Allergan, Inc. v. Ferrum Ferro Capital, LLC (C.D. Cal. 2015)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2015-06-19 | 1 | Complaint (Attorney Civil Case Opening) | Batoosingh , including U.S. Patent Nos. 7,030,149 (“the ’149 patent”), 7,320,976, 22 7,642,258, 8,133,890…interest in each of 24 these six patents, including the ’149 patent. 25 22. COMBIGAN® or…claim of each of the six patents listed above, including the 27 ’149 patent. 28 23. Because…expiration of 7 Allergan’s patents covering COMBIGAN®, including the ’149 patent. These 8 ANDAs were filed…infringed Allergan’s duly issued patents, including 13 the ’149 patent. 14 25. In response, | External link to document |
| 2015-08-10 | 26 | Motion to Strike | Partes Review of U.S. Patent 9 No. 7,030,149 (hereinafter the “‘149 patent”) as the America Invents…four patents, finding them obvious and therefore not patentable. 9 As to the fourth patent, the …petitioning the United States Patent and Trademark Office’s 9 (“USPTO’s”) Patent Trial & Appeal Board…FFC’s position that Claim 4 of the ‘149 Patent is non-patentable as 24 obvious, Allergan cannot demonstrate… claims of the '463 patent 16 and claim 4 of the '149 patent cannot be reconciled. 17 | External link to document |
| 2015-08-10 | 27 | Exhibit A - Allergan v Sandoz ED TX | United States Patent Nos. 7,030,149 (―the ‗149 patent‖); 7,320,976 (―the ‗976 patent‖); 7,323,463 (… The Patents-in-Suit 31. The patents-in-suit are U.S. Patent Nos. 7,030,149 (―the ‗149… (―the ‗463 patent‖); and 7,642,258 (―the ‗258 patent‖) (collectively, the ―patents-in-suit‖). The Court…claim 4 of the ‗149 Patent, claim 1 of the ‗976 patent, claims 1-6 of the ‗463 Patent, and claims 1-9 of…‗149 patent‖); 7,320,976 (―the ‗976 patent‖); 7,323,463 (―the ‗463 patent‖); and 7,642,258 (―the ‗258 | External link to document |
| 2015-08-10 | 28 | Exhibit 4 - Plaintiffs' First RPD to KB | 4. "The '149 patent" means U.S. Patent No. 7,030,149. 22 5. &…work with Regarding the validity or patentability of the '149 patent. 4 II REQUEST FOR PRODUCTION …) Concerning any Allergan patent, Including any "other Combigan patents 8 II listed in the FDA Orange…IPR petition that FFC flied against the '149 patent. 24 II REQUEST FOR PRODUCTION NO…9, 2015 IPR petition flied against the '149 patent. 27 28 | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
